Correction of metabolic acidosis in hemodialysis: consequences on serum leptin and mineral metabolism

International Urology and Nephrology

Volumn 47, Issue 1, 2015, Pages 177-182

  Bales, Alessandra M ^a   Moysés, Rosa M A ^a   dos Reis, Luciene M ^a   Graciolli, Fabiana G ^a   Hung, James ^a   Martins Castro, Manuel Carlos ^a   Elias, Rosilene M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Hemodialysis; Leptin; Metabolic acidosis; Parathyroid hormone

Indexed keywords

ADIPONECTIN; BETA 2 MICROGLOBULIN; BICARBONATE; CALCIUM; DIALYSIS FLUID; LEPTIN; PARATHYROID HORMONE; PHOSPHATE; SERUM ALBUMIN;

ACIDOSIS; ADULT; BLOOD; BLOOD GAS ANALYSIS; CHEMISTRY; FEMALE; HUMAN; KIDNEY FAILURE, CHRONIC; MALE; METABOLISM; MIDDLE AGED; PH; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; SEX DIFFERENCE; YOUNG ADULT;

ACIDOSIS; ADIPONECTIN; ADULT; BETA 2-MICROGLOBULIN; BICARBONATES; BLOOD GAS ANALYSIS; CALCIUM; DIALYSIS SOLUTIONS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY FAILURE, CHRONIC; LEPTIN; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; PROSPECTIVE STUDIES; RENAL DIALYSIS; SERUM ALBUMIN; SEX FACTORS; YOUNG ADULT;

EID: 84940005607     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-014-0844-5     Document Type: Article

References (38)

1. Kopple JD, Kalantar-Zadeh K, Mehrotra R (2005) Risks of chronic metabolic acidosis in patients with chronic kidney disease. Kidney Int 67(Suppl):S21–S27
2. Kovacic V, Roguljic L, Kovacic V (2003) Metabolic acidosis of chronically hemodialyzed patients. Am J Nephrol 23:158–164
3. Mehrotra R, Kopple JD, Wolfson M (2003) Metabolic acidosis in maintenance dialysis patients: clinical considerations. Kidney Int 63(Suppl):S13–S25
4. Kraut JA, Kurtz I (2005) Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. Am J Kidney Dis 45:978–993
5. Reaich D, Channon SM, Scrimgeour CM, Daley SE, Wilkinson R et al (1993) Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. Am J Physiol 265:E230–E235
6. Castaneda-Sceppa C, Sarnak MJ, Wang X, Greene T, Madero M et al (2007) Role of adipose tissue in determining muscle mass in patients with chronic kidney disease. J Ren Nutr 17:314–322
7. Aguilera A, Bajo MA, Rebollo F, Diez JJ, Diaz C et al (2002) Leptin as a marker of nutrition and cardiovascular risk in peritoneal dialysis patients. Adv Perit Dial 18:212–217
8. Mora Palma FJ, Ellis HA, Cook DB, Dewar JH, Ward MK et al (1983) Osteomalacia in patients with chronic renal failure before dialysis or transplantation. Q J Med 52:332–348
9. Burton RF (1992) The roles of intracellular buffers and bone mineral in the regulation of acid-base balance in mammals. Comp Biochem Physiol Comp Physiol 102:425–432
10. Green J, Kleeman CR (1991) The role of bone in the regulation of systemic acid-base balance. Contrib Nephrol 91:61–76
11. Bushinsky DA (1995) Stimulated osteoclastic and suppressed osteoblastic activity in metabolic but not respiratory acidosis. Am J Physiol 268:C80–C88
12. Krieger NS, Sessler NE, Bushinsky DA (1992) Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro. Am J Physiol 262:F442–F448
13. Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG et al (2001) Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 16:1426–1433
14. Margetic S, Gazzola C, Pegg GG, Hill RA (2002) Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 26:1407–1433
15. Daugirdas JT (1989) The post: pre dialysis plasma urea nitrogen ratio to estimate K.t/V and NPCR: validation. Int J Artif Organs 12:420–427
16. Kim HJ, Han SW (2007) Metabolic acidosis in maintenance hemodialysis patients: clinical impact and intervention. Electrolyte Blood Press 5:42–46
17. Movilli E, Gaggia P, Camerini C, Brunori G, Vizzardi V et al (2005) Effect of oral sodium bicarbonate supplementation on interdialytic weight gain, plasma sodium concentrations and predialysis blood pressure in hemodialysis patients. Blood Purif 23:379–383
18. Brady JP, Hasbargen JA (2000) A review of the effects of correction of acidosis on nutrition in dialysis patients. Semin Dial 13:252–255
19. Avesani CM, Draibe SA, Kamimura MA, Dalboni MA, Colugnati FA et al (2004) Decreased resting energy expenditure in non-dialysed chronic kidney disease patients. Nephrol Dial Transplant 19:3091–3097
20. Bossola M, Tazza L, Giungi S, Luciani G (2006) Anorexia in hemodialysis patients: an update. Kidney Int 70:417–422
21. Bergstrom J (1995) Nutrition and mortality in hemodialysis. J Am Soc Nephrol 6:1329–1341
22. Nasri H (2006) Serum leptin concentration and left ventricular hypertrophy and function in maintenance hemodialysis patients. Minerva Urol Nefrol 58:189–193
23. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J et al (2001) Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104:3052–3056
24. Kokot F, Chudek J, Adamczak M, Wiecek A (2001) Interrelationship between plasma leptin concentration and severity of metabolic acidosis in haemodialysed patients with chronical renal failure. Exp Clin Endocrinol Diabetes 109:370–373
25. Fluck CE, Kuhlmann BV, Mullis PE (1999) Insulin increases serum leptin concentrations in children and adolescents with newly diagnosed type I diabetes mellitus with and without ketoacidosis. Diabetologia 42:1067–1070
26. Hathout EH, Sharkey J, Racine M, Ahn D, Mace JW et al (1999) Changes in plasma leptin during the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab 84:4545–4548
27. Malyszko J, Malyszko J, Wolczynski S, Mysliwiec M (2006) Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related? Nephrol Dial Transplant 21:145–152
28. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H et al (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100:2473–2476
29. Teta D, Maillard M, Halabi G, Burnier M (2008) The leptin/adiponectin ratio: potential implications for peritoneal dialysis. Kidney Int 73(Suppl):S112–S118
30. Kraut JA (2000) Disturbances of acid-base balance and bone disease in end-stage renal disease. Semin Dial 13:261–266
31. Lefebvre A, de Vernejoul MC, Gueris J, Goldfarb B, Graulet AM et al (1989) Optimal correction of acidosis changes progression of dialysis osteodystrophy. Kidney Int 36:1112–1118
32. Confavreux CB (2011) Bone: from a reservoir of minerals to a regulator of energy metabolism. Kidney Int 79(Suppl):S14–S19
33. Cornish J, Callon KE, Bava U, Lin C, Naot D et al (2002) Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175:405–415
34. Coen G, Ballanti P, Fischer MS, Balducci A, Calabria S et al (2003) Serum leptin in dialysis renal osteodystrophy. Am J Kidney Dis 42:1036–1042
35. Kokot F, Chudek J, Karkoszka H, Adamczak M, Wiecek A et al (1999) Does PTH influence leptin concentration in haemodialysed uraemic patients? Nephron 82:372–373
36. Zoccali C, Panuccio V, Tripepi G, Cutrupi S, Pizzini P et al (2004) Leptin and biochemical markers of bone turnover in dialysis patients. J Nephrol 17:253–260
37. Merabet E, Dagogo-Jack S, Coyne DW, Klein S, Santiago JV et al (1997) Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 82:847–850
38. Polymeris A, Doumouchtsis K, Grapsa E (2012) Bone mineral density and bone metabolism in hemodialysis patients. Correlation with PTH, 25OHD3 and leptin. Nefrologia 32:73–78